Ritu Aneja
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$415KFederal grants as PI2 awards
4Patents grantedLatest Mar 26, 2019
7Papers67 citations
Federal awards and patents by year
AwardsPatents
2 awards · $415K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 1, 2015 | NIH | STTR Phase I A novel racial disparity marker for risk prediction in triple negative breast cancer patients | $208K | NOVAZOI THERANOSTICS with GEORGIA STATE UNIVERSITY |
| Jul 30, 2015 | NIH | STTR Phase I A novel racial disparity marker for risk prediction in triple negative breast cancer patients | $208K | NOVAZOI THERANOSTICS |
5 patents as inventor
- US 10213448NOVAZOI THERANOSTICSFeb 26, 2019
- US 10242153NOVAZOI THERANOSTICSMar 26, 2019
- US 9589100NOVAZOI THERANOSTICSMar 7, 2017
- US 9857354NOVAZOI THERANOSTICSJan 2, 2018
- US NOVAZOI THERANOSTICS—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,591
Awards as PI#1,252
Patents#41
Companies
- NOVAZOI THERANOSTICSLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.